Giardina C, Serio G, Lepore G, Lettini T, Dalena A M, Pennella A, D'Eredità G, Valente T, Ricco R
Dept. of Pathological Anatomy and Genetics, University of Bari, Italy.
J Exp Clin Cancer Res. 2003 Jun;22(2):279-88.
Nuclear pleomorphism is a fundamental feature in evaluating the aggressiveness of ductal carcinoma in situ (DCIS) of the breast. In this study, pure DCIS and the in situ component (IS-comp) of invasive duct carcinoma (IDC) are compared in order to verify if these are two different entities or the same process observed at different times during its evolution. Five cases of pure DCIS and nine of IDC with extensive in situ component were selected. They were moderately and poorly differentiated. 30 nuclei for each DCIS, and 30 nuclei for both the in situ and invasive component of each IDC were studied; thus, a total of 720 nuclei were submitted to the SAM (Shape Analytical Morphometry) analysis, which enables a numerical expression not only of dimensions (area, perimeter, diameter) but also of nuclear contour irregularities and nuclear shape distortions. Univariate statistical comparisons were carried out between the nuclei of: (1) DCIS and in situ component of invasive duct carcinoma, (2) DCIS and the invasive component of infiltrating carcinoma and (3) between the in situ and invasive component of infiltrating carcinoma. Multivariate analysis was utilized to compare nuclei of DCIS with the in situ component of IDC. The in situ features of each tumor were also evaluated with the mitotic index (MI). Nuclei of pure DCIS resulted significantly larger (p < 0.001) and with a more regular shape (p < 0.001) than those of the in situ component of IDC. No differences were observed between the nuclei of the in situ and the invasive component of infiltrating carcinomas. Multivariate statistical analysis discriminated 77% of nuclei of in situ proliferation when both G2 and G3 tumors were considered, and 80% when only G3 tumors were considered. In conclusions morphological differences exist between pure DCIS and the in situ component of IDC, which may be an expression of their biological behavior; moreover, these morphological differences seem to have a better discriminating power within the same histological grade.
核多形性是评估乳腺导管原位癌(DCIS)侵袭性的一个基本特征。在本研究中,对纯DCIS和浸润性导管癌(IDC)的原位成分(IS-comp)进行比较,以验证它们是两个不同的实体,还是在其演变过程中不同时间观察到的同一过程。选取了5例纯DCIS和9例具有广泛原位成分的IDC。它们为中分化和低分化。对每个DCIS的30个细胞核,以及每个IDC的原位和浸润成分的30个细胞核进行研究;因此,总共720个细胞核接受了SAM(形状分析形态测量法)分析,该方法不仅能对尺寸(面积、周长、直径)进行数值表达,还能对核轮廓不规则性和核形状畸变进行数值表达。对以下细胞核进行了单变量统计比较:(1)DCIS和浸润性导管癌的原位成分,(2)DCIS和浸润性癌的浸润成分,以及(3)浸润性癌的原位和浸润成分之间。采用多变量分析比较DCIS的细胞核与IDC的原位成分。还通过有丝分裂指数(MI)评估了每个肿瘤的原位特征。纯DCIS的细胞核比IDC的原位成分的细胞核显著更大(p < 0.001)且形状更规则(p < 0.001)。浸润性癌的原位和浸润成分的细胞核之间未观察到差异。当同时考虑G2和G3肿瘤时,多变量统计分析能区分77%的原位增殖细胞核;当仅考虑G3肿瘤时,能区分80%。总之,纯DCIS和IDC的原位成分之间存在形态学差异,这可能是它们生物学行为的一种表现;此外,这些形态学差异在相同组织学分级内似乎具有更好的鉴别能力。